Table 3.
Analysis of proteins modulated by anthraquinone derivatives
| Pathway ID | Description | Number of genes | Matching genes |
|---|---|---|---|
| hsa05200 | Pathways in cancer | 3 | SP1, IL23A, NFE2L2 |
| hsa05164 | Influenza A | 2 | NXT2, SP1 |
| hsa05133 | Pertussis | 2 | SP1, IL23A |
| ko04625 | C-Type lectin receptor signaling pathway | 2 | SP1, IL23A |
| hsa05166 | HTLV-I infection | 1 | CHEK1 |
| hsa05014 | Amyotrophic lateral sclerosis (ALS) | 1 | SP1 |
| hsa05152 | Tuberculosis | 1 | IL23A |
| hsa05224 | Breast cancer | 1 | SP1 |
| hsa05204 | Chemical carcinogenesis | 1 | CBR1 |
| hsa05225 | Hepatocellular carcinoma | 1 | NFE2L2 |
| hsa05203 | Viral carcinogenesis | 1 | CHEK1 |
| hsa04216 | Ferroptosis | 1 | GSS |
| hsa05323 | Rheumatoid arthritis | 1 | IL23A |
| hsa01524 | Platinum drug resistance | 1 | TOP2A |
| hsa04115 | p53 signaling pathway | 1 | CHEK1 |